Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required
No abstract is available for this record.
Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Bibliographic context
- Journal
- Drugs & Therapy Perspectives
- Date
- 2025-11-04
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
psilocybin DepressionAddictionChronic PainClinical TrialRandomized Controlled TrialTreatment-Resistant DepressionToxicity Randomized Controlled Trial PsilocybinAntidepressantPsychiatryMajor depressive disorderDepression (economics)PsychotherapistPsychologyHallucinogenDepressive symptomsLegislationLegislatureTreatment-resistant depressionClinical psychologyRandomized controlled trialMedicineAdjunctive treatmentClinical trialPharmacotherapyMEDLINEAnhedonia
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?Clinical Pharmacology & Therapeutics · 2023-10-04S1 Appendix - Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trialFigshare · 2025-09-18The Utility of Psilocybin in Managing Anxiety and Depression in Cancer PatientsBiochemistry and Molecular Biology Education · 2018-07-31Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders?Research Directions Depression · 2023-10-12Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2019-12-31Can Psilocybin Treat Severe DepressionJournal watch · 2017-11-02Psilocybin to Manage Cancer-Related DepressionUnknown journal · 2016-12-20